Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Wisaksana, Rudi ^a,b   Sumantri, Rachmat ^a   Indrati, Agnes R ^a,b   Zwitser, Aleta ^c   Jusuf, Hadi ^a   de Mast, Quirijn ^c   van Crevel, Reinout ^b,c   van der Ven, Andre ^c  

^a Hasan Sadikin Hospital   (Indonesia)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anemia; HIV; Iron

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; ZIDOVUDINE; IRON; TRANSFERRIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDONESIA; IRON BALANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROTEIN ANALYSIS; SEROPREVALENCE; VIRUS TRANSMISSION; BLOOD; COHORT ANALYSIS; HOMEOSTASIS; METABOLISM; SURVIVAL;

ADULT; ANEMIA; COHORT STUDIES; FEMALE; FERRITINS; HIV INFECTIONS; HOMEOSTASIS; HUMANS; INDONESIA; IRON; MALE; SURVIVAL ANALYSIS; TRANSFERRIN;

EID: 79961138102     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-213     Document Type: Article

References (43)

1. Belperio PS, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):27S-43S.
2. Lundgren JD, Mocroft A. Anemia and survival in human immunodeficiency virus. Clin Infect Dis 2003, 37(Suppl 4):S297-S303.
3. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PCK, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YA, Sunkanuparph S, Tau G, Zhang F, Lee CKC, Diatngco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis 2009, 48(7):940-50.
4. Volberding PA, Levine AM, Dieterich D, Mildvan D, Mitsuyasu R, Saag M. Anemia in HIV infection: clinical impact and evidence-based management strategies. Clin Infect Dis 2004, 38(10):1454-63.
5. Kreuzer KA, Rockstroh JK. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997, 75(5-6):179-87.
6. Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response - lessons from malaria and human immunodeficiency virus. Ann Clin Biochem 2008, 45(Pt 1):18-32.
7. Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol 2008, 6(7):541-52.
8. Ganz T. The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease. Isr Med Assoc J 2002, 4(11):1043-5.
9. Vyoral D, Petrak J. Hepcidin: a direct link between iron metabolism and immunity. Int J Biochem Cell Biol 2005, 37(9):1768-73.
10. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005, 352(10):1011-23.
11. Gordeuk VR, Delanghe JR, Langlois MR, Boelaert JR. Iron status and the outcome of HIV infection: an overview. J Clin Virol 2001, 20(3):111-5.
12. Savarino A, Pescarmona GP, Boelaert JR. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences?. Cell Biochem Funct 1999, 17(4):279-87.
13. Gordeuk VR, Onojobi G, Schneider MF, Dawkins MF, Delapenha R, Voloshin Y, von Wyi V, Bacon M, Minkoff H, Levine A, Cohen M, Greenblatt RM. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica 2006, 91(6):739-43.
14. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, Austin S, Jeffries D, Awasana AA, Whittle HC, Prentice AM. Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 2007, 46(4):498-507.
15. Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level Assessing the Iron Status of Population: Report of a Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level. 2005, Malta: World Health Organization, Joint World Health Organization/Centers for Disease Control and Prevention Technical Consultation on the Assessment of Iron Status at the Population Level.
16. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003, 329(1-2):9-22.
17. Mburu AS, Thurnham DI, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multi-micronutrient supplement in apparently healthy, HIV+ Kenyan adults. J Nutr 2008, 138(3):613-9.
18. Salome MA, Grotto HZ. Human immunodeficiency virus-related anemia of chronic disease: relationship to hematologic, immune, and iron metabolism parameters, and lack of association with serum interferon-gamma levels. AIDS Patient Care STDS 2002, 16(8):361-5.
19. Sarcletti M, Quirchmair G, Weiss G, Fuchs D, Zangerle R. Increase of haemoglobin levels by anti-retroviral therapy is associated with a decrease in immune activation. Eur J Haematol 2003, 70(1):17-25.
20. Boom J, Kosters E, Duncombe C, Kerr S, Hisrchel B, Ruxrungtham K, de Mast Q, Kosalaraksa P, Ulbolyam S, Jupimai T, Ananworanich J, . the Staccato Study Group Ferritin levels during structured treatment interruption of highly active antiretroviral therapy. HIV Med 2007, 8(6):388-95. the Staccato Study Group.
21. Costantini A, Giuliodoro S, Butini L, Silvestri G, Leoni P, Montroni M. Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. J Acquir Immune Defic Syndr 2009, 52(1):70-4.
22. Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, Busti F, Campostrini N, Martinelli N, Vantini I, Corrocher R, Ganz T, Fattovich G. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009, 51(5):845-52.
23. Wisaksana R, Indrati AK, Fibriani A, Rogayah E, Sudjana P, Djajakusumah TS, Sumantri R, Alisjahbana B, van der Ven A, van Crevel R. Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia. Addiction 2010, 105(6):1055-61.
24. Departemen Kesehatan Republik Indonesia Pedoman nasional terapi antiretroviral. 2007, Departemen Kesehatan Republik Indonesia.
25. World Health Organization Antiretroviral Therapy for HIV infection in adults and adolescents in resources-limited settings: Toward Universal Access. 2006, 68-71. Geneva, World Health Organization.
26. Greer JP, Foerster J, Lukens JN. Wintrobe's Clinical Hematology 2003, Lippincot Williams & Wilkins Publisher, 11.
27. de Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993-2005: WHO Global Database on Anaemia. 2008, Spain: World Health Organization.
28. Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev 2002, 4(1):13-20.
29. Lidya, Rutherford M, Apriani L, Janssen W, Rahmadi A, Parwati I, Yuwono A, van Crevel R. Improving Diagnosis of Pulmonary Tuberculosis Among HIV/AIDS Patients: Literature Review and Experience in a Teaching Hospital in Indonesia. Acta Medica Indonesiana 2009, 41(Supplement 1):57-64.
30. McDermid JM, van der Loeff MF, Jaye A, Hennig BJ, Bates C, Todd J, Sirugo G, Hill AV, Whittle HC, Prentice AM. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am J Clin Nutr 2009, 90(1):225-33.
31. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998, 91(1):301-8.
32. Kiragga AN, Castelnuovo B, Nakanjako D, Manabe YC. Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. J Int AIDS Soc 2010, 13:42.
33. Boelaert JR, Weinberg GA, Weinberg ED. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 1996, 5(1):36-46.
34. Rawat R, Stoltzfus RJ, Ntozini R, Mutasa K, Iliff PJ, Humphrey JH. Influence of inflammation as measured by alpha-1-acid glycoprotein on iron status indicators among HIV-positive postpartum Zimbabwean women. Eur J Clin Nutr 2009, 63(6):787-93.
35. Kupka R, Msamanga GI, Mugusi F, Petraro P, Hunter DJ, Fawzi WW. Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression. J Nutr 2007, 137(10):2317-23.
36. Semba RD, Kumwenda N, Hoover DR, Taha TE, Mtimavalye L, Broadhead R, Eisinger W, Miotti PG, Chiphangwi JD. Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi. Eur J Clin Nutr 2000, 54(12):872-7.
37. Dikshit B, Wanchu A, Sachdeva RK, Sharma A, Das R. Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disord 2009, 9:5.
38. Koorts AM, Viljoen M. Ferritin and ferritin isoforms II: protection against uncontrolled cellular proliferation, oxidative damage and inflammatory processes. Arch Physiol Biochem 2007, 113(2):55-64.
39. Wanchu A, Rana SV, Pallikkuth S, Sachdeva RK. Short communication: oxidative stress in HIV-infected individuals: a cross-sectional study. AIDS Res Hum Retroviruses 2009, 25(12):1307-11.
40. Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, Xu XN. HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci USA 2005, 102(31):11017-22.
41. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002, 99(10):3505-16.
42. Semba RD, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002, 34(2):260-6.
43. Semba RD, Ricketts EP, Mehta S, Netski D, Thomas D, Kirk G, Wu AW, Vlahov D. Effect of micronutrients and iron supplementation on hemoglobin, iron status, and plasma hepatitis C and HIV RNA levels in female injection drug users: a controlled clinical trial. J Acquir Immune Defic Syndr 2007, 45(3):298-303.